Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 15/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5204407 | 0.85 | PTGS2 (0.53) | KMT2APTGS2PTGS1CYP2C9 | |
| SCHEMBL27611192 | 0.85 | PTGS2 (0.51) | KMT2APTGS2PTGS1CYP2C9 | |
| SCHEMBL5203297 | 0.84 | PTGS2 (0.49) | KMT2APTGS2PTGS1 | |
| SCHEMBL6885294 | 0.82 | PTGS2 (0.65) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL5202675 | 0.82 | PTGS2 (0.65) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL5273552 | 0.80 | PTGS2 (0.48) | KMT2APTGS2PTGS1CYP2C9 | |
| SCHEMBL5202685 | 0.80 | PTGS2 (0.45) | PTGS2PTGS1CYP1A2CYP2C9 | |
| SCHEMBL5204765 | 0.79 | PTGS2 (0.58) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL5207543 | 0.79 | PTGS2 (0.67) | PTGS2PTGS1CYP2C9 | |
| SCHEMBL27611206 | 0.78 | PTGS2 (0.51) | PTGS2PTGS1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6803380-B1 | NON-STEROIDAL ANTIINFLAMMATORY DRUGS | LABORATOIRE THERAMEX (MC) | 2004-10-12 | — | — | US | disclosed |
| EP-1246809-B1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THERAMEX (MC) | 2003-07-16 | — | — | EP | disclosed |
| EP-1246809-A1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001034577-A1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2001-05-17 | — | — | WO | disclosed |
| EP-1099695-A1 | 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | LABORATOIRE THERAMEX S.A. (MC) | 2001-05-16 | — | — | EP | disclosed |